Transcription of retinoic acid receptor genes in transgenic mice increases CD8 T-cell subset.
Retinoic acid (RA), a vitamin A derivative is known to have a number of effects on the immune system such as inducing cytotoxic T-lymphocytes in vivo and inducing the rejection of skin grafts. However, the molecular mechanisms of these actions are unclear. The retinoic acid receptors which belong to the steroid/thyroid receptor superfamily, are known to bind to regulatory elements of certain genes thereby regulating gene transcription. To determine if expression of retinoic acid receptors in vivo under normal physiological conditions is also regulating genes involved in immunological function, we assayed the human retinoic acid receptor gamma gene driven by a T-cell specific lck-promoter in transgenic mice. Using FACS analysis, we showed that mice expressing the RAR gamma-transgene had significantly increased numbers of CD4-/CD8+ cells compared to controls.
Department of Immunology, Research Institute of Scripps Clinic, La Jolla, Calif.
J
J
Pohl
D
D
LaFace
J F
JF
Sands
D000818:Animals; D001483:Base Sequence; D016516:CD4-CD8 Ratio; D016827:CD8 Antigens; D002352:Carrier Proteins / Q000235:genetics*; D004247:DNA / Q000235:genetics; D051379:Mice; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D018168:Receptors, Retinoic Acid; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014158:Transcription, Genetic; D014212:Tretinoin / Q000378:metabolism*
D016827:CD8 Antigens; D002352:Carrier Proteins; D018168:Receptors, Retinoic Acid; D014212:Tretinoin; D004247:DNA